Based on the naranjo adverse drug reaction probability scale and the WHO-Uppsala Monitoring Centre (WHO-UMC) causality assessment system, the association between tirzepatide and rhabdomyolysis was classified as probable. To our knowledge, no previous cases of tirzepatide-induced rhabdomyolysis for T2DM have been reported in the literature
Why that selectivity exists at the receptor level isnt entirely settled it may reflect biased agonism, where the specific binding geometry favors the somatotroph signaling pathway over the corticotroph one, even though both cell populations express GHSR-1a
Collagen lm cng da, duy tr m, ngn nga kh nhn, lo ha sm
Chatkin JM, Zani-Silva L, Ferreira I, Zamel N
Ida S, Kaneko R, Imataka K, et al
check_circle Research Use Only Products are clearly labeled and intended exclusively for qualified research purposes